| Issue Date | Title | Author(s) |
| 11-Aug-2020 | Adsorption and activation of molecular oxygen over atomic copper(I/II) site on ceria | Kang, Liqun; Wang, Bolun; Bing, Qiming; Zalibera, Michal; Buechel, Robert; Xu, Ruoyu; Wang, Qiming; Liu, Yiyun; Gianolio, Diego; Tang, Chiu C.; Gibson, Emma K.; Danaie, Mohsen; Allen, Christopher; Wu, Ke; Marlow, Sushila; Sun, Ling-dong; He, Qian; Guan, Shaoliang; Savitsky, Anton; Velasco-Velez, Juan J.; Callison, June; Kay, Christopher W. M.; Pratsinis, Sotiris E.; Lubitz, Wolfgang; Liu, Jing-yao; Wang, Feng Ryan |
| 1-Jun-2024 | ARTEMIS-001: Data from a phase 1a/b study of HS-20093 in patients with relapsed small cell lung cancer (SCLC). | Wang, Jie; Duan, Jianchun; Sun, Yuping; Xing, Ligang; Han, Liang; Wang, Qiming; Wu, Lin; Chen, Jianhua; Lu, Ping; Guo, Wei; Wang, Haiying; Liu, Baogang; Zhang, Zhiye; Zhang, Junhong; Huang, Jianying; Shi, Huaqiu; Yang, Haiyu; Zhang, Guoping; Ning, Fangling; Zhu, Weiliang |
| 1-Jun-2023 | ARTEMIS-001: Phase 1 study of HS-20093, a B7-H3-targeting antibody-drug conjugate, in patients with advanced solid tumor | Wang, Jie; Duan, Jianchun; Xing, Ligang; Sun, Yuping; Guo, Wei; Wang, Haiying; Chen, Jianhua; Han, Liang; Liu, Baogang; Wang, Qiming; Hu, Ying; Wei, Hongying; Li, Chuan; Huang, Qiqi; Dong, Yiwei; Wu, Qiong |
| 2019 | Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non-Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel | Wang, Zhijie; Duan, Jianchun; Cai, Shangli; Han, Miao; Dong, Hua; Zhao, Jun; Zhu, Bo; Wang, Shuhang; Zhuo, Minglei; Sun, Jianguo; Wang, Qiming; Bai, Hua; Han, Jiefei; Tian, Yanhua; Lu, Jing; Xu, Tongfu; Zhao, Xiaochen; Wang, Guoqiang; Cao, Xinkai; Li, Fugen; Wang, Dalei; Chen, Yuejun; Bai, Yuezong; Zhao, Jing; Zhao, Zhengyi; Zhang, Yuzi; Xiong, Lei; He, Jie; Gao, Shugeng; Wang, Jie |
| Feb-2021 | Camrelizumab Plus Apatinib in Extensive-Stage SCLC (PASSION): A Multicenter, Two-Stage, Phase 2 Trial | Fan, Yun; Zhao, Jun; Wang, Qiming; Huang, Dingzhi; Li, Xingya; Chen, Jianhua; Fang, Yong; Duan, Jianchun; Zhou, Caicun; Hu, Yanping; Yang, Haihua; Hu, Yi; Zhou, Jianying; Lin, Xiaoyan; Wang, Lifeng; Wang, Zhijie; Xu, Yanjun; Zhang, Tao; Shi, Wei; Zou, Jianjun; Wang, Jie |
| Aug-2020 | Camrelizumab plus apatinib in extensive-stage small-cell lung cancer (PASSION): A multicenter, two-stage, phase 2 trial | Wang, Jie; Fan, Yun; Zhao, Jun; Wang, Qiming; Huang, Dingzhi; Li, Xingya; Chen, Jianhua; Fang, Yong; Wang, Zhijie; Zhou, Caicun; Hu, Yanping; Yang, Haihua; Hu, Yi; Zhou, Jianying; Lin, Xiaoyan; Wang, Lifeng; Xu, Yanjun; Li, Hanying |
| 26-Nov-2024 | Camrelizumab plus carboplatin and pemetrexed as first-line therapy for advanced non-squamous non-small-cell lung cancer: 5-year outcomes of the CameL randomized phase 3 study | Zhou, Caicun; Chen, Gongyan; Huang, Yunchao; Zhou, Jianying; Lin, Lizhu; Feng, Jifeng; Wang, Zhehai; Shu, Yongqian; Shi, Jianhua; Hu, Yi; Wang, Qiming; Cheng, Ying; Wu, Fengying; Chen, Jianhua; Lin, Xiaoyan; Wang, Yongsheng; Huang, Jianan; Cui, Jiuwei; Cao, Lejie; Liu, Yunpeng; Zhang, Yiping; Pan, Yueyin; Zhao, Jun; Wang, Liping; Chang, Jianhua; Chen, Qun; Ren, Xiubao; Zhang, Wei; Fan, Yun; He, Zhiyong; Fang, Jian; Gu, Kangsheng; Dong, Xiaorong; Jin, Faguang; Gao, Hongjun; An, Guangyu; Ding, Cuimin; Jiang, Xiaodong; Xiong, Jianping; Zhou, Xiangdong; Hu, Sheng; Lu, Ping; Liu, Anwen; Guo, Shuliang; Huang, Jianjin; Zhu, Chengchu; Zhao, Jian; Gao, Beili; Chen, Yinglan; Hu, Chengping; Zhang, Jian; Zhang, Hongmei; Zhao, Hui; Wang, Zhigao; Ma, Xinjing; Shi, Wei |
| Apr-2023 | Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors | Xu, Chunwei; Zhang, Yongchang; Wang, Wenxian; Chu, Qian; Li, Ziming; Song, Zhengbo; Wang, Jiandong; Yu, Jinpu; Liu, Jingjing; Zhang, Shirong; Cai, Xiuyu; Wu, Ming; Zhan, Ping; Liu, Hongbing; Lv, Tangfeng; Miao, Liyun; Min, Lingfeng; Li, Jiancheng; Liu, Baogang; Yuan, Jingping; Jiang, Zhansheng; Lin, Gen; Chen, Xiaohui; Pu, Xingxiang; Rao, Chuangzhou; Lv, Dongqing; Yu, Zongyang; Li, Xiaoyan; Tang, Chuanhao; Zhou, Chengzhi; Zhang, Junping; Guo, Hui; Chu, Qian; Meng, Rui; Liu, Xuewen; Wu, Jingxun; Hu, Xiao; Fang, Min; Kang, Jin; Zhu, Zhengfei; Chen, Xiaofeng; Pan, Weiwei; Pang, Fei; Zhou, Yuxiang; Jian, Qijie; Wang, Kai; Wang, Liping; Zhu, Youcai; Yang, Guocai; Lin, Xinqing; Cai, Jing; Liang, Lijun; Feng, Huijing; Wang, Lin; Du, Yingying; Yao, Wang; Shi, Xuefei; Niu, Xiaomin; Yuan, Dongmei; Yao, Yanwen; Huang, Jianhui; Zhang, Yinbin; Sun, Pingli; Wang, Hong; Ye, Mingxiang; Wang, Dong; Wang, Zhaofeng; Hao, Yue; Wang, Zhen; Wan, Bing; Lv, Donglai; Yu, Genhua; Li, Anna; Kang, Jin; Zhang, Jiatao; Zhang, Chao; Chen, Huafei; Wu, Lin; Ye, Leiguang; Wang, Gaoming; Wang, Yina; Gao, Feng; Zhou, Wei; Hu, Chunxiu; Wei, Jianguo; Li, Bihui; Li, Zhongwu; Li, Yuan; Liu, Zhefeng; Yang, Nong; Wu, Lin; Wang, Qiming; Huang, Wenbin; Hong, Zhuan; Wang, Guansong; Fang, Meiyu; Song, Yong; Zhu, Xixu; Du, Kaiqi; Ji, Jiansong; Shen, Yi; Zhang, Yiping; Ma, Shenglin; Song, Yong; Lu, Yuanzhi; Liu, Anwen; Fang, Wenfeng; Zhong, Wenzhao |
| 13-Sep-2024 | Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer | Cheng, Ying; Spigel, David R.; Cho, Byoung Chul; Laktionov, Konstantin K.; Fang, Jian; Chen, Yuanbin; Zenke, Yoshitaka; Lee, Ki Hyeong; Wang, Qiming; Navarro, Alejandro; Bernabe, Reyes; Buchmeier, Eva Lotte; Chang, John Wen-Cheng; Shiraishi, Yoshimasa; Goksu, Sema Sezgin; Badzio, Andrzej; Shi, Anhui; Daniel, Davey B.; Hoa, Nguyen Thi Thai; Zemanova, Milada; Mann, Helen; Gowda, Hema; Jiang, Haiyi; Senan, Suresh |
| Mar-2020 | Generation of human hepatocytes from extended pluripotent stem cells | Wang, Qiming; Sun, Da; Liang, Zhen; Wang, Junyi; Zhong, Xinxing; Lyu, Yulin; Cao, Junning; Lin, Zhongqing; Du, Yuanyuan; Miao, Zhenchuan; Lu, Shichun; Li, Cheng; Xu, Jun; Shi, Yan; Deng, Hongkui |
| 1998 | Investigation on the luminescence properties of Er ions in Er-doped sol-gel silica glasses | Xie, Datao; Wu, Jinguang; Xu, Duanfu; Hu, Tiandou; Zhou, Weijin; Xu, Guangxian; Wang, Qiming; Yang, Qinqing; Lei, Hongbing |
| Nov-2022 | Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non-small-cell lung cancer characterizes the features of response to PD-1 blockade plus chemotherapy | Wu, Fengying; Jiang, Tao; Chen, Gongyan; Huang, Yunchao; Zhou, Jianying; Lin, Lizhu; Feng, Jifeng; Wang, Zhehai; Shu, Yongqian; Shi, Jianhua; Hu, Yi; Wang, Qiming; Cheng, Ying; Chen, Jianhua; Lin, Xiaoyan; Wang, Yongsheng; Huang, Jianan; Cui, Jiuwei; Cao, Lejie; Liu, Yunpeng; Zhang, Yiping; Pan, Yueyin; Zhao, Jun; Wang, LiPing; Chang, Jianhua; Chen, Qun; Ren, Xiubao; Zhang, Wei; Fan, Yun; He, Zhiyong; Fang, Jian; Gu, Kangsheng; Dong, Xiaorong; Zhang, Tao; Shi, Wei; Zou, Jianjun; Bai, Xuejuan; Ren, Shengxiang; Zhou, Caicun |
| 2017 | National Clinical Skills Competition for Medical Students in China | Liu, Jing; Jiang, Guanchao; Zhou, Qinghuan; Chen, Hong; Wang, Shan; Wang, Qiming; Chi, Baorong; He, Qingnan; Xiao, Haipeng |
| 2016 | National Clinical Skills Competition: an effective simulation-based method to improve undergraduate medical education in China | Jiang, Guanchao; Chen, Hong; Wang, Qiming; Chi, Baorong; He, Qingnan; Xiao, Haipeng; Zhou, Qinghuan; Liu, Jing; Wang, Shan |
| 20-Aug-2020 | Pyrotinib in HER2-Mutant Advanced Lung Adenocarcinoma After Platinum-Based Chemotherapy: A Multicenter, Open-Label, Single-Arm, Phase II Study | Zhou, Caicun; Li, Xingya; Wang, Qiming; Gao, Guanghui; Zhang, Yiping; Chen, Jianhua; Shu, Yongqian; Hu, Yanping; Fan, Yun; Fang, Jian; Chen, Gongyan; Zhao, Jun; He, Jianxing; Wu, Fengying; Zou, Jianjun; Zhu, Xiaoyu; Lin, Xiang |
| Sep-2022 | Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blin | Lu, Shun; Wu, Lin; Jian, Hong; Chen, Ying; Wang, Qiming; Fang, Jian; Wang, Ziping; Hu, Yanping; Sun, Meili; Han, Liang; Miao, Liyun; Ding, Cuimin; Cui, Jiuwei; Li, Baolan; Pan, Yueyin; Li, Xingya; Ye, Feng; Liu, Anwen; Wang, Ke; Cang, Shundong; Zhou, Hui; Sun, Xing; Ferry, David; Lin, Yong; Wang, Shuyan; Zhang, Wen; Zhang, Chengli |
| Jul-2023 | Sintilimab plus chemotherapy for patients with EGFR- mutated non-squamous non-small-cell lung cancer with disease progression after EGFRtyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double- blind, randomised, placebo-control | Lu, Shun; Wu, Lin; Jian, Hong; Cheng, Ying; Wang, Qiming; Fang, Jian; Wang, Ziping; Hu, Yanping; Han, Liang; Sun, Meili; Miao, Liyun; Ding, Cuimin; Cui, Jiuwei; Wang, Ke; Li, Baolan; Li, Xingya; Ye, Feng; Liu, Anwen; Pan, Yueyin; Cang, Shundong; Zhou, Hui; Sun, Xing; Shen, Yuping; Wang, Shuyan; Zhang, Wen; He, Yue |
| Jul-2023 | Sintilimab plus chemotherapy for patients with EGFR- mutated non-squamous non-small-cell lung cancer with disease progression after EGFRtyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double- blind, randomised, placebo-control | Lu, Shun; Wu, Lin; Jian, Hong; Cheng, Ying; Wang, Qiming; Fang, Jian; Wang, Ziping; Hu, Yanping; Han, Liang; Sun, Meili; Miao, Liyun; Ding, Cuimin; Cui, Jiuwei; Wang, Ke; Li, Baolan; Li, Xingya; Ye, Feng; Liu, Anwen; Pan, Yueyin; Cang, Shundong; Zhou, Hui; Sun, Xing; Shen, Yuping; Wang, Shuyan; Zhang, Wen; He, Yue |
| 2019 | A two-step lineage reprogramming strategy to generate functionally competent human hepatocytes from fibroblasts | Xie, Bingqing; Sun, Da; Du, Yuanyuan; Jia, Jun; Sun, Shicheng; Xu, Jun; Liu, Yifang; Xiang, Chengang; Chen, Sitong; Xie, Huangfan; Wang, Qiming; Li, Guangya; Lyu, Xuehui; Shen, Hui; Li, Shiyu; Wu, Min; Zhang, Xiaonan; Pu, Yue; Xiang, Kuanhui; Lai, Weifeng; Du, Peng; Yuan, Zhenghong; Li, Cheng; Shi, Yan; Lu, Shichun; Deng, Hongkui |
